Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael R. Berman is active.

Publication


Featured researches published by Michael R. Berman.


Current Eye Research | 1991

Pathogenesis of corneal epithelial defects: Role of plasminogen activator

Ken Hayashi; Michael R. Berman; Don Smith; Aly El-ghatit; Steven Pease; Kenneth R. Kenyon

Previous studies have suggested that the plasminogen activator (PA)/plasmin system has important roles in the pathogenesis of epithelial defects and stromal ulceration. The current studies were performed to localize PA species and identify them as tissue-type PA (tPA) or urokinase-like PA (uPA) as the two have distinct regulatory properties potentially related to the mechanisms of defect formation and ulceration. To determine the locations and types of PA species, antibodies to tPA or to uPA or the drug amiloride (a drug that inhibits uPA but not tPA) were incorporated into fibrin/fibronectin (Fn) clots overlying frozen sections to block regional fibrinolysis. Normal rabbit eyes showed tPA activity in association with corneal epithelium, corneal endothelium, and ciliary body/iris. After epithelial scrape or alkali burn, corneal tPA activity was detected initially in the defect zone colinear with fibrin/Fn and was symmetrical to resurfacing epithelium. The observation that initial fibrinolysis occurs in the defect zone, known to contain fibrin/Fn, suggests that tPA from blood (limbal vascular endothelium) and/or from corneal epithelium has become bound to (and activated on) the fibrin/Fn. PA activity was also associated with the leading edges of migrating epithelium post-scrape and post-burn and was not inhibited by antibodies to either tPA or uPA but was inhibited by amiloride. After complete closure of the primary defect post-scrape, only tPA appeared to be associated with the epithelium in that all PA activity was inhibited by antibodies to tPA. The observation that leading edge activity post-burn, in correlation with the formation of secondary defects, continues to be inhibitable by amiloride but not by antibodies to tPA suggests that uPA remains abnormally on the leading edge, and that sustained uPA activity in that location results in inappropriate degradation of subepithelial fibrin/Fn to result in a defect. Successful regulation of uPA activity at the leading edge of corneal epithelium post-burn would be expected to be useful therapeutically in the healing of epithelial defects and the prevention of stromal ulceration.


Journal of Molecular and Cellular Cardiology | 1988

Effect of isoproterenol on force transient time course and on stiffness spectra in rabbit papillary muscle in barium contracture

Michael R. Berman; Jon N. Peterson; David T. Yue

To determine whether catecholamines produce alterations in myocardial myosin-actin cycling kinetics, we investigated the effects of isoproterenol upon mechanical characteristics of constantly activated heart muscle thought to reflect crossbridge behavior. In isolated rabbit right ventricular papillary muscles in barium contracture at 24 degrees C, we found that 10 microM isoproterenol caused: (a) a 23% reduction of the 10 to 90% rise time of slow tension recovery in force transients induced by rapid, small amplitude stretches; and (b) a 23% increase in the frequency of sinusoidal length perturbation at which stiffness amplitude exhibited a minimum. Based upon previous mechanistic interpretations of force transients, and on an analysis developed here to relate crossbridge events to the frequency-dependence of stiffness, we argue that our observations provide evidence that isoproterenol induces an acceleration of crossbridge cycling rate. This raises the intriguing prospect that beta-adrenergic stimulation regulates contraction, not only by well-known alterations in calcium metabolism, but also by intrinsic modulation of the force-generating machinery itself.


Anesthesiology | 1989

Depression of myocardial force and stiffness without change in crossbridge kinetics: effects of volatile anesthetics reproduced by nifedipine

Ok Yung Chung; Thomas J. J. Blanck; Michael R. Berman

The authors examined the effects of nifedipine, a sarcolemmal slow Ca2+ channel blocker, on dynamic stiffness and force of rabbit right ventricular trabeculum and papillary muscle in Ba2+ contracture, in an attempt to reproduce the effects of halothane, enflurane, and isoflurane on a similar preparation as reported by Shibata et al. Once barium contracture force was established, muscle length was perturbed with small amplitude sinusoidal oscillations in the frequency range of 0.1-100 Hz. Nifedipine 1 microM was then added to the superfusate and dynamic stiffness was again measured. Additional barium was used to determine restoration of contracture force to and beyond control levels. Nifedipine produced a significant decrease in contracture force and high-frequency stiffness with no effect on the frequency (fmin) at which stiffness amplitude exhibited a minimum (P less than 0.005). Contracture force and stiffness could be restored by adding additional barium to the nifedipine-treated muscles. These results are similar to those reported by Shibata et al. using volatile anesthetics. Since nifedipine, which acts specifically at the sarcolemmal slow Ca2+ channel, affects contracture force and dynamic stiffness in this preparation in a manner similar to the volatile anesthetics, the authors suggest that the anesthetics studied by Shibata et al. may well exert a significant component of their negative inotropic activity via their action on the sarcolemmal slow Ca2+ channel.


Advances in Experimental Medicine and Biology | 1991

Evidence for a Halothane-Induced Reduction in Maximal Calcium-Activated Force in Mammalian Myocardium

Michael R. Berman; Eugenie S. Casella; Thomas J. J. Blanck

In addition to their general anesthetic effects, the halogenated volatile anesthetics (e.g., halothane, enflurane, isoflurane) are known to significantly depress cardiac contractility. In the late 1960’s, Goldberg and Ullrick1 reported a dose-dependent and reversible depression of twitch force by halothane (as delivered by a calibrated vaporizer) in the range of 0.1% to 2.35%. They argued that “… halothane seems to exert its cardiac effects primarily by decreasing the intensity of the active state. …” In a comparative study of the effects of several general anesthetic agents on cardiac contractility, Brown and Crout2 reported similar results for halothane as well as for methoxyflurane. They, too, suggested that these agents exerted their cardio-depressive effects via a diminution of the active state of cardiac muscle. Although the concept of “active state” is no longer useful, it is known to be associated with the calcium transient; that is, the rapid rise and fall of intracellular free calcium concentration seen subsequent to electrical stimulation.


Anesthesiology | 1991

Ejection Fraction Revisited

James L. Robotham; Masao Takata; Michael R. Berman; Yasuhiko Harasawa


Investigative Ophthalmology & Visual Science | 1979

Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Evidence for the role of polymorphonuclear leukocytes in collagen degradation.

Kenneth R. Kenyon; Michael R. Berman; Jeannette Rose; Janet Gage


Investigative Ophthalmology & Visual Science | 1982

Plasminogen activator (urokinase) causes vascularization of the cornea.

Michael R. Berman; S Winthrop; D Ausprunk; J Rose; Robert Langer; Janet Gage


Investigative Ophthalmology & Visual Science | 1980

Stromal vascularization prevents corneal ulceration.

Conn H; Michael R. Berman; Kenneth R. Kenyon; Robert Langer; Janet Gage


Investigative Ophthalmology & Visual Science | 1988

Plasminogen activator activity in vitamin A-deficient rat corneas.

Ken Hayashi; G Frangieh; Kenneth R. Kenyon; Michael R. Berman; G Wolf


Journal of Molecular and Cellular Cardiology | 1992

The mechanism of final force decline in isolated rabbit papillary muscle

Jon N. Peterson; Michael R. Berman

Collaboration


Dive into the Michael R. Berman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Langer

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James L. Robotham

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Aly El-ghatit

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge